Phase III clinical trial - Sein Adjuvant

ASTEFANIA (WO42633 )
Sein Adjuvant
Ouvert depuis le: 12.05.2021
Site: Paris
Ouvert depuis le: 10.04.2021
Site: Saint-Cloud
Public cible
Adulte
A Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Description de l'essai

This is a Phase III, two-arm, randomized, double-blind placebo-controlled study in participants with HER2-positive primary breast cancer who have received preoperative chemotherapy and HER2-directed therapy, including trastuzumab followed by surgery, with a finding of residual invasive disease in the breast and/or axillary lymph nodes.